Significance of Cardiac Troponin in Cancer Patients
Cells · 10.08.2026 · 15 (16) · 1435
DOI: 10.3390/cells15161435 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 10.08.2026. Verfasst von Kristóf Birgés und 2 weiteren Autor:innen. Beteiligte Einrichtung: Heart and Vascular Center, Semmelweis University, 1122 Budapest, Hungary. Hauptthemen laut MEDLINE: Neoplasms, Troponin, Myocardium. Die Arbeit nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Recent advances in oncological therapies have significantly improved cancer survival rates. However, these therapies have also led to an increased risk of cardiovascular alterations. Cardiac troponin, which is well-known for its role in diagnosing myocardial damage, is gaining recognition as a biomarker in the field of cardio-oncology. Despite its clinical value, differential diagnosis remains challenging, as troponin levels can increase in numerous scenarios, particularly in cardio-oncology. While the most recognized cause is the cardiotoxicity associated with cancer therapy, malignant tumors may also directly impact the myocardium. Furthermore, different cardiac troponins, such as troponins T and I, may have distinct biomarker roles, adding to diagnostic complexity. This review aims to summarize the pathological conditions that cause elevated serum cardiac troponin levels in patients with malignancies. We explore the underlying mechanisms at the molecular and cellular levels and discuss potential clinical applications. We also highlight existing gaps in the current evidence and outline future research directions in this rapidly evolving field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heart and Vascular Center, Semmelweis University, 1122 Budapest, Hungary.
ORCID-Profile: Kristóf Birgés, Béla Merkely
Förderung
- European Union
Zitieren
APA
Birgés, K., Merkely, B., & Molnár, A. Á. (2026). Significance of Cardiac Troponin in Cancer Patients. Cells, 15(16), 1435. https://doi.org/10.3390/cells15161435
Vancouver
Birgés K, Merkely B, Molnár AÁ. Significance of Cardiac Troponin in Cancer Patients. Cells. 2026;15(16):1435. doi:10.3390/cells15161435
BibTeX
@article{Birgs2026,
author = {Birgés, Kristóf and Merkely, Béla and Molnár, Andrea Ágnes},
title = {Significance of Cardiac Troponin in Cancer Patients},
journal = {Cells},
year = {2026},
volume = {15},
number = {16},
pages = {1435},
doi = {10.3390/cells15161435}
}
EUVIMED